← Back to Vaccine Database

V160

Live attenuated vaccine · VDDBV0746

Target & Classification

CMVCytomegalovirus
Live attenuated vaccine
Cytomegalovirus Infections
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials3

NCT IDPhaseDisease / Condition
NCT01986010 Phase 1Cytomegalovirus Infections
NCT03486834 Phase 2Cytomegalovirus Infections
NCT03840174 Phase 1Cytomegalovirus Infections